Literature DB >> 16211198

Kawasaki disease hospitalizations in a predominantly African-American population.

Walid M Abuhammour1, Rashed A Hasan, Ahmed Eljamal, Basim Asmar.   

Abstract

This is a descriptive study of the occurrence of Kawasaki disease (KD) in an urban population that was a majority of African Americans. Records of 189 children (mean age, 2.9 +/- 2.2 years [range: 2 months to 11.1 years]) hospitalized for KD over 8 years (January 1, 1992 to December 31, 1999) were reviewed and data analyzed. One hundred thirty-six (72%) were African American (AA), 43 (23%) were white, and 9 (5%) children were "others.'' The annual frequency was 15 for AA and 7.7 for white per 100,000 5-year-old children. Coronary artery abnormalities (CAA) were reported in 21 (11%) children (18 [13.2%] of 136 AA, and 3 [4.7%] of 43 whites [p=0.095]). AA children with CAA were older than their white counterparts (26 to 24 vs. 5 to 2.8 months, p=0.03). There was a higher occurrence in winter and spring (110 cases [58%] vs. 79 cases [42%]) compared to summer and fall. KD occurrence was positively associated with average monthly snowfall (r=0.35, p=0.004) and inversely associated with average monthly temperature (r = - 0.2, p=0.048). African-American children were more likely to be hospitalized for KD compared to white children. The association of KD with temperature and precipitation suggest that it is influenced by environmental factors.

Entities:  

Mesh:

Year:  2005        PMID: 16211198     DOI: 10.1177/000992280504400812

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  6 in total

1.  PRINCESS: Privacy-protecting Rare disease International Network Collaboration via Encryption through Software guard extensionS.

Authors:  Feng Chen; Shuang Wang; Xiaoqian Jiang; Sijie Ding; Yao Lu; Jihoon Kim; S Cenk Sahinalp; Chisato Shimizu; Jane C Burns; Victoria J Wright; Eileen Png; Martin L Hibberd; David D Lloyd; Hai Yang; Amalio Telenti; Cinnamon S Bloss; Dov Fox; Kristin Lauter; Lucila Ohno-Machado
Journal:  Bioinformatics       Date:  2017-03-15       Impact factor: 6.937

2.  Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial.

Authors:  Michael A Portman; Nagib S Dahdah; April Slee; Aaron K Olson; Nadine F Choueiter; Brian D Soriano; Sujatha Buddhe; Carolyn A Altman
Journal:  Pediatrics       Date:  2019-05-02       Impact factor: 7.124

Review 3.  Systemic vasculitis in childhood.

Authors:  Abraham Gedalia; Raquel Cuchacovich
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

4.  Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility.

Authors:  Jihoon Kim; Chisato Shimizu; Stephen F Kingsmore; Narayanan Veeraraghavan; Eric Levy; Andre M Ribeiro Dos Santos; Hai Yang; Jay Flatley; Long Truong Hoang; Martin L Hibberd; Adriana H Tremoulet; Olivier Harismendy; Lucila Ohno-Machado; Jane C Burns
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

Review 5.  Kawasaki disease: 40 years after the original report.

Authors:  Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

6.  Kawasaki Disease and Clinical Outcome Disparities Among Black Children.

Authors:  Luz A Padilla; Jacqueline L Collins; Adeniyi J Idigo; Yung Lau; Michael A Portman; Sadeep Shrestha
Journal:  J Pediatr       Date:  2020-09-24       Impact factor: 4.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.